STAT+: Nobel-winning optogenetics research has led to experimental treatments for blindness and Alzheimer’s
Optogenetics is now the foundational way through which we are able to understand how the brain works
Nobel laureate Karl Deisseroth, along with German researchers Peter Hegemann and Georg Nagel, received accolades on Monday for their groundbreaking work in optogenetics. This pioneering research has paved the way for experimental treatments targeting conditions like blindness and Alzheimer's disease. Deisseroth, a Stanford University and Howard Hughes Medical Institute researcher, emphasized the complexity of the human brain and the need for precise tools to decode its workings.
He explained that our perception of reality and inner states arise from individual cells, making targeted treatments essential.
Written by urgent.news from STAT News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
